Author

Catherine D. Falkenstein

Children's Hospital of PhiladelphiaORCID 0009-0005-1032-9138Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Adolfo A. FerrandoiD· 1 shared Andrei Thomas‐TikhonenkoiD· 1 shared Annette CastroiD· 1 shared Caleb M. RadensiD· 1 shared Clara RegleroiD· 1 shared Katharina E. HayeriD· 1 shared Manuel Torres-DiziD· 1 shared Marilyn M. LiiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adolfo A. FerrandoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer ResearchPeer-reviewedAug 2, 2024

An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia

Manuel Torres-Diz, Clara Reglero, Catherine D. Falkenstein…·Andrei Thomas‐Tikhonenko

The paper identifies an alternatively spliced NT5C2 isoform contributing to chemoresistance in B-ALL by enhancing nucleosidase activity and 6-MP resistance.

13 citations

humanbulk RNA-seq

𝕏 PostBluesky